September 5, 2017
Mitsubishi Tanabe Pharma is working to strengthen its sales and marketing activities in the field of products for autoimmune diseases including Remicade (infliximab). This move comes after approvals of an additional indication of ulcerative colitis for Simponi (golimumab) and Crohn’s...read more